Mandate

Vinge advises Gotlandsbolaget on its investment in shipping of the future

February 14, 2025 Maritime and Transport Law

Gotlandsbolaget has taken an important step towards a more sustainable future by ordering the high-speed catamaran Gotland Horizon X, which will be powered by fossil-free fuels. For Vinge, it has been a privilege to provide advice to Gotlandsbolaget during the process.

The vessel, built by the Australian shipyard Austal, will be a pioneering example of the sustainable ferry service of the future. The advice has covered the drafting and negotiation of shipbuilding contracts as well as intellectual property issues. With our support, Gotlandsbolaget, Sweden’s oldest passenger shipping company, has been able to focus on developing a solution that not only benefits the ferry-service to Gotland, but also contributes to the transition of shipping towards a climate-neutral future.

A sustainable solution for Gotland transport

The Gotland Horizon X will be a fast catamaran with room for 1,500 passengers and 400 cars, which can run on several types of fossil-free fuels. The vessel will be able to travel at 29 knots, giving a crossing time between Gotland and the mainland of just over 3 hours.

Vinge looks forward to following the development and is proud to have been part of Gotlandsbolaget's important investment in sustainability and innovation.

Vinge’s team consisted of Paula Bäckdén, Alexander Lindeberg and Imola Szanto Francsics.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025